The Enterprise Value as of December 2024 (TTM) for Astellas Pharma Inc. (ALPMY) is 3.39T

According to Astellas Pharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.39T. This represents a change of -5.85% compared to the average of 3.61T of the last 4 quarters.

Astellas Pharma Inc. (ALPMY) Historical Enterprise Value (quarterly & annually)

How has ALPMY Enterprise Value performed in the past?

The mean historical Enterprise Value of Astellas Pharma Inc. over the last ten years is 3.21T. The current 3.39T Enterprise Value has changed 10.47% with respect to the historical average. Over the past ten years (40 quarters), ALPMY's Enterprise Value was at its highest in in the September 2023 quarter at 4.27T. The Enterprise Value was at its lowest in in the December 2018 quarter at 2.36T.

Astellas Pharma Inc. (ALPMY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Astellas Pharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Astellas Pharma Inc. (ALPMY) Average Enterprise Value

How has ALPMY Enterprise Value performed in the past?

The current Enterprise Value of Astellas Pharma Inc. (ALPMY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Astellas Pharma Inc. (ALPMY) Enterprise Value vs. Peers

How is ALPMY’s Enterprise Value compared to its peers?

Astellas Pharma Inc.’s Enterprise Value is greater than Bristol-Myers Squibb Company PFD CONV 2 (160.66B), less than Daiichi Sankyo Company, Limited (0), less than AstraZeneca PLC (7.78T), greater than Astellas Pharma Inc. (229.37B), less than Bayer Aktiengesellschaft (3.39T), greater than Otsuka Holdings Co., Ltd. (13.94B), less than Pfizer Inc. (4.42T), greater than Luye Pharma Group Ltd. (216.04B), greater than Sanofi (13.79B), greater than Amarin Corporation plc (131.44B), greater than Novartis AG (35.80M), greater than null (209.26B),

Build a custom stock screener for Astellas Pharma Inc. (ALPMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Astellas Pharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Astellas Pharma Inc. (ALPMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Astellas Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.